Ragamac, Reyvin .
HRN: 25-99-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/14/2024
12/21/2024
IV
2.2g
Q6hours
Presumptive PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes